1 / 48

OVERVIEW BIOTECHNOLOGY IN INDONESIA

OVERVIEW BIOTECHNOLOGY IN INDONESIA. T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI).

claude
Download Presentation

OVERVIEW BIOTECHNOLOGY IN INDONESIA

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OVERVIEW BIOTECHNOLOGY IN INDONESIA T.Basuki, L.B.S. Kardono & M. Hanafi Research Center for Chemistry Indonesian Institute of Sciences (LIPI)

  2. Biotechnology, in wider sense, in Indonesia can be said having meaning both of old biotechnology (such as tempe-fermented soybean, tape-fermented cassava/glutinous rice) and new biotechnology (such as protein structure, third generation biotechnology) • Biotechnology consists of Traditional and Modern Biotech: Medical, Agro, Environmental, Chemical, and Food Biotechnology • Third Generation Biotech= Functional Genomics and Proteomics • Targeted Medicine, Tissue Engineering and Stem cells, should be the Focus for Asia • BINASIA should become the Information Hub for Biotech Asia • Governments must stimulate Innovation in R&D through various Incentives

  3. The Central Dogma of Molecular Biology

  4. The Scientific Development of Biotechnology and Its Industrial Applications

  5. Targeted medicine, Tissue engineering and Stem cells • Because people have a different genetic make up, the effect of drugs will also differ. This new branch of medicine is now called pharmacogenetics, which study the effect of drugs on genetically different populations. It is now known that treatment of hypertension, cancers, and other diseases will result in a negative response in certain groups of patients, resulting in waste of money as well as exposing unnecessary adverse reactions to patients.

  6. TARGETED THERAPY • Targeted therapy addresses the needs of specific patient populations. Patients want to know whether they are likely to benefit from a drug, while minimizing their risk of negative side effects. • Targeted medicine may improve drug efficacy by better understanding the genetic associations to disease. • Identifying patients most likely respond to a specific drug will improve patient compliance with a therapy. This is especially true in patients with oncology therapy, where the side effect are severe. Herceptin, a drug for breast cancer patients is the prototype drug.

  7. TISSUE ENGINEERING • Tissue engineering, is also a new field and hold many promises and potentials for future therapy. • From the internet, the topic of “tissue engineering” generates a response of 593,000 hits. So, enough literature to search and read.

  8. STEM CELLS • Stem cell or Regenerative Medicine is very much related with tissue engineering. It is basically a new science which is developed from embryology and cloning research. • When an oocyte is fertilized by sperm to become a zygote, at the blastocyst stage, an inner mass is formed, which is pluripotent, meaning that these cells can differentiate into all 210 tissue in the body. • Presently, much research is done to direct the development of these embryonic stem cells, to cardiomyocytes, dopaminergic nerve cells, beta-cells of Langerhans, and neurons. • In mice, good results have been achieved to replace infarcted tissue by new cardiomyocytes, pancreatic cells, neurons and other tissues.

  9. The Future of Regenerative Medicine/Stem Cells

  10. Nucleus of patient transferred to enucleated human oocyte.Inner cell mass from blastocyst cultured and stimulated to form specific cell types required for THERAPY----Diabetes, Parkinson, Cancer, Stroke etc,

  11. The Chemo-attractive homing hypothesis of circulating STEM CELLS, attracted to injury, in the infarcted area

  12. Biotechnology: Present and Future

  13. Development of Biotechnology in Indonesia is started in the mid 1980’s • Under the coordination of • Ministry of Education • Ministry of Research and Technology • Ministry of Agriculture • Ministry of Health

  14. INDONESIA BIOTECHNOLOGY CONSORTIUM (Konsorsium Bioteknologi Indonesia) • Established on October 14, 1994 • 34 Institutions: 11 (RC); 10 (University), 3 (BPPT), 5 Industries, 2 Hospitals • Founding members: 3 IUC Biotechnology (ITB, IPB, UGM) Members : RC from Universities (Public and Private) RC from Department and non-Department Institutions from private sectors/industries

  15. Universitas Diponegoro Universitas Indonesia Universitas Soedirman Universitas Brawijaya Universitas Udayana Inst Teknologi Indonesia Univ Muhamadiyah Malang Universitas Lampung Universitas Surabaya Universitas Negeri Malang MEMBERS OF KBI (1)RESEARCH AND DEVELOPMENT CENTERSUniversities (Public - Private)

  16. MEMBERS OF KBI (2)RESEARCH AND DEVELOPMENT CENTER ON BIOTECHNOLOGY • Mininistry of Research and Technology • Center for the assessment biotech (BPPT) • Center for the assessment and application bioindustry technology (BPPT) • Starch Technology Center (BPPT) • LIPI • Research Center for Biotechnology • Research Center for Chemistry • Department of Agriculture • Research Center of Agriculture & Genetics Resources • Research Center for Horticuluture • Biotech Research Unit for Crops Estate

  17. MEMBERS OF KBI (3)INSTITUTIONS FROM PRIVATE SECTORS/INDUSTRIES • PT. ESA MEDIKA MANDIRI • PT SENTRA BIOSAINS DINAMIKA • PT MONAGRO KIMIA • PT FAJAR MAS MURNI • PT EAST WEST SEED INDONESIA • HOSPITALS : • Rajawali Hospital • Tegalrejo Hospital

  18. ROLE OF INDONESIA BIOTECHNOLOGY CONSORTIUM • GOVERNMENT: POLICY IN BIOTECHNOLOGY SECTOR • MEMBERS: • SHARING INFORMATION AND RESOURCES JOINT ACTIVITIES • INDONESIA BIOTECHNOLOGY CONFERENCE

  19. Strategic Plan ofthe Development of Biotechnology in Indonesia KBI involves in preparing a concept of Strategic Plan of the Development of Biotechnology in Indonesia (“SPDBI”), from 2002-2004. This effort was under the coordination of the Ministry of Research and Technology

  20. Biotechnology applications in three main fields have been elaborated in “SPDBI”: • Medicine and human health; • Agriculture, food production, and fisheries; • Industries, environment protection and remediation

  21. Biotechnology Research Priorities in the field Medicine and human health • Genetics disorders, • Infectious diseases, • Degenerative and malignancy diseases

  22. Biotechnology Research Priorities in the field Agriculture, and marine • Isolation and identification of abiotic stress resistance gene(s) markers • Field tests for efficacy and food safety, • Development of diagnostic kit for marine pollutant and pathogens

  23. Biotechnology Research Priorities in the field of industries, environments protection and remediation • Development of recombinant vaccine production • Development of novel antibiotics from local microbes • Environment protection and bioremediation

  24. The critical success factors for the development of biotechnology: • Infrastructure development, • Regulatory/cultural environment, • Policy development, • Human resource development, • Finance and resource mobilization

  25. Must pay attention & consider • Socio-cultural and esthetical • Religious and ethical norm

  26. MOLECULAR BIOTECHNOLOGYIN INDONESIA

  27. Biotechnology application in food production in Indonesia • Tissue culture • Marker aided selection • Transgenesis • Genomics – ‘functional genomics’ –

  28. Tissue culture • Plant tissue culture and micropropagation techniques are well established in several laboratories • Commercial production : banana, oil palm, orchid, teak and fast growing trees

  29. λHindIII transgenic Non transgenic Transgenic Indonesian aromatic rice resistant to yellow stem borer insect– approved for limited field trial – LIPI (Indonesian Institute of Sciences) cry1Ab cry1Ab

  30. Other transgenic plants develop in Indonesia i.e.:

  31. proteomics Data mining Genome sequence Functional analysis of unknown ORFs transcriptomics • Transcriptome • Global gene regulation • Differential gene expression • Proteome • Protein level • Protein interactions • Structure/function • Metabolome • Kinetic parameter • Modeling metabolic pw DNA Microarray • Bioinformatics • Statistics • Linking database • Pattern recognition • Whole cell simulations Metabolome Functional Genomics sequence Functional genomics Applications

  32. Recommendations • Considering the limited financial and human resources Indonesia, therefore, focus of the focus of all Biotechnology field must be taken • The Government must STIMULATE INNOVATION by giving TAX INCENTIVES to industries doing R&D • Efforts must be made to Facilitate Government-University-Industry cooperation • Applied Research in Universities and Government institutions should be done in close cooperation with industries • BINASIA should become the communication hub for International Cooperation and Technology Transfer

  33. Recommendations (cont. ……………..) • In order to understand better on BINASIA, IBC –particularly IBC member’s institutions- are encouraged to open the website http://www.binasia.net/home.asp and to fill their specific activities accordingly. • IBC periodical meeting should cover report on the progress of IBC member institutions to engage with the respective institution(s) from other BINASIA member countries.

  34. THANK YOU

More Related